Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Tackling the complexities of antiviral access criteria
+News
Tackling the complexities of antiviral access criteria
Friday 22 July 2022, 10:51 AM

Paxlovid is one of the antivirals now available for COVID-19 patients who qualify [image: Kches16414, CC BY-SA 4.0 / WikiCommons]
Amy van der Loo rounds up the clinical education content in the latest issue of New Zealand Doctor Rata Aotearoa. Use the embedded links to go through to the relevant page
For this issue, we prepared two articles to help explain the Pharmac access criteria for COVID-19 antiviral treatments. However, as we went to print,
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.